JP Patent

JP6940411B2 — Ｅｔｃ１００２及びエゼチミブを含む固定用量組合せ物及び製剤並びに心血管疾患を処置するか又は心血管疾患のリスクを低減させる方法

Assigned to Esperion Therapeutics Inc · Expires 2021-09-29 · 5y expired

What this patent protects

Patent listed against Nexletol.

Drugs covered by this patent

Patent Metadata

Patent number
JP6940411B2
Jurisdiction
JP
Classification
—
Expires
2021-09-29
Drug substance claim
No
Drug product claim
No
Assignee
Esperion Therapeutics Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.